55 related articles for article (PubMed ID: 20937525)
1. Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma.
Lassus H; Staff S; Leminen A; Isola J; Butzow R
Gynecol Oncol; 2011 Jan; 120(1):11-7. PubMed ID: 20937525
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis of MIR182 and its associated target genes in advanced ovarian carcinoma.
McMillen BD; Aponte MM; Liu Z; Helenowski IB; Scholtens DM; Buttin BM; Wei JJ
Mod Pathol; 2012 Dec; 25(12):1644-53. PubMed ID: 22790015
[TBL] [Abstract][Full Text] [Related]
3. The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.
Smith P; Bradley T; Gavarró LM; Goranova T; Ennis DP; Mirza HB; De Silva D; Piskorz AM; Sauer CM; Al-Khalidi S; Funingana IG; Reinius MAV; Giannone G; Lewsley LA; Stobo J; McQueen J; Bryson G; Eldridge M; ; Macintyre G; Markowetz F; Brenton JD; McNeish IA
Nat Commun; 2023 Jul; 14(1):4387. PubMed ID: 37474499
[TBL] [Abstract][Full Text] [Related]
4. Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats.
Li JJ; Weroha SJ; Lingle WL; Papa D; Salisbury JL; Li SA
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18123-8. PubMed ID: 15601761
[TBL] [Abstract][Full Text] [Related]
5. High Expression of SQSTM1/p62 Protein Is Associated with Poor Prognosis in Epithelial Ovarian Cancer.
Iwadate R; Inoue J; Tsuda H; Takano M; Furuya K; Hirasawa A; Aoki D; Inazawa J
Acta Histochem Cytochem; 2014; 47(6):295-301. PubMed ID: 25859063
[TBL] [Abstract][Full Text] [Related]
6. Research progress on the relationship between AURKA and tumorigenesis: the neglected nuclear function of AURKA.
Chen M; Zhu H; Li J; Luo D; Zhang J; Liu W; Wang J
Ann Med; 2024 Dec; 56(1):2282184. PubMed ID: 38738386
[TBL] [Abstract][Full Text] [Related]
7. Aurora kinase a inhibitor MLN8237 suppresses pancreatic cancer growth.
Zhang Y; Ma Y; Wang Y; Mukhopadhyay D; Bi Y; Ji B
Pancreatology; 2022 Jun; 22(5):619-625. PubMed ID: 35550115
[TBL] [Abstract][Full Text] [Related]
8. Autophagy modulating therapeutics inhibit ovarian cancer colony generation by polyploid giant cancer cells (PGCCs).
Bowers RR; Andrade MF; Jones CM; White-Gilbertson S; Voelkel-Johnson C; Delaney JR
BMC Cancer; 2022 Apr; 22(1):410. PubMed ID: 35421971
[TBL] [Abstract][Full Text] [Related]
9. Aurora-A kinase is differentially expressed in the nucleus and cytoplasm in normal Müllerian epithelium and benign, borderline and malignant serous ovarian neoplasms.
Alkhateeb KJ; Crane JE; Sak M; Jorgensen CJ; O'Donnell JP; Zumbar CT; Wozniak JA; Salazar CR; Parwani AV; Lehman NL
Diagn Pathol; 2021 Oct; 16(1):98. PubMed ID: 34706741
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Aurora kinase A triggers programmed death-ligand 1-mediated immune suppression by activating MYC transcription in triple-negative breast cancer.
Sun S; Zhou W; Li X; Peng F; Yan M; Zhan Y; An F; Li X; Liu Y; Liu Q; Piao H
Cancer Commun (Lond); 2021 Sep; 41(9):851-866. PubMed ID: 34251762
[TBL] [Abstract][Full Text] [Related]
11. Nuclear localisation of Aurora-A: its regulation and significance for Aurora-A functions in cancer.
Naso FD; Boi D; Ascanelli C; Pamfil G; Lindon C; Paiardini A; Guarguaglini G
Oncogene; 2021 Jun; 40(23):3917-3928. PubMed ID: 33981003
[TBL] [Abstract][Full Text] [Related]
12. Aurora kinases in ovarian cancer.
Pérez-Fidalgo JA; Gambardella V; Pineda B; Burgues O; Piñero O; Cervantes A
ESMO Open; 2020 Oct; 5(5):e000718. PubMed ID: 33087400
[TBL] [Abstract][Full Text] [Related]
13. DNA alteration-based classification of uveal melanoma gives better prognostic stratification than immune infiltration, which has a neutral effect in high-risk group.
Narasimhaiah D; Legrand C; Damotte D; Remark R; Munda M; De Potter P; Coulie PG; Vikkula M; Godfraind C
Cancer Med; 2019 Jun; 8(6):3036-3046. PubMed ID: 31025552
[TBL] [Abstract][Full Text] [Related]
14. Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer.
Jacobsen A; Bosch LJW; Martens-de Kemp SR; Carvalho B; Sillars-Hardebol AH; Dobson RJ; de Rinaldis E; Meijer GA; Abeln S; Heringa J; Fijneman RJA; Feenstra KA
Sci Rep; 2018 May; 8(1):7522. PubMed ID: 29760449
[TBL] [Abstract][Full Text] [Related]
15. Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy.
Li M; Li H; Liu F; Bi R; Tu X; Chen L; Ye S; Cheng X
J Ovarian Res; 2017 Feb; 10(1):9. PubMed ID: 28187748
[TBL] [Abstract][Full Text] [Related]
16. Aurora kinase A interacts with H-Ras and potentiates Ras-MAPK signaling.
Umstead M; Xiong J; Qi Q; Du Y; Fu H
Oncotarget; 2017 Apr; 8(17):28359-28372. PubMed ID: 28177880
[TBL] [Abstract][Full Text] [Related]
17. DNA Cytometry and Nuclear Morphometry in Ovarian Benign, Borderline and Malignant Tumors.
El Din AA; Badawi MA; Aal SE; Ibrahim NA; Morsy FA; Shaffie NM
Open Access Maced J Med Sci; 2015 Dec; 3(4):537-44. PubMed ID: 27275284
[TBL] [Abstract][Full Text] [Related]
18. The p38 MAPK inhibitor BIRB796 enhances the antitumor effects of VX680 in cervical cancer.
Jin X; Mo Q; Zhang Y; Gao Y; Wu Y; Li J; Hao X; Ma D; Gao Q; Chen P
Cancer Biol Ther; 2016 May; 17(5):566-76. PubMed ID: 27082306
[TBL] [Abstract][Full Text] [Related]
19. A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas.
Mittal K; Choi DH; Klimov S; Pawar S; Kaur R; Mitra AK; Gupta MV; Sams R; Cantuaria G; Rida PCG; Aneja R
J Ovarian Res; 2016 Mar; 9():17. PubMed ID: 26992853
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
